Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.

MLA

Ichikawa, Kunimoto, et al. “Co-Occurrence of Hyperleukocytosis and Elevated Fibrin-Fibrinogen Degradation Product Levels Is a Risk Factor for Early Intracranial Hemorrhage in Patients with de Novo Acute Leukemia.” International Journal of Hematology, vol. 104, no. 5, Nov. 2016, pp. 612–20. EBSCOhost, https://doi.org/10.1007/s12185-016-2072-5.

APA

Ichikawa, K., Edahiro, Y., Gotoh, A., Iiduka, K., Komatsu, N., & Koike, M. (2016). Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia. International Journal of Hematology, 104(5), 612–620. https://doi.org/10.1007/s12185-016-2072-5

Chicago

Ichikawa, Kunimoto, Yoko Edahiro, Akihiko Gotoh, Kazuhide Iiduka, Norio Komatsu, and Michiaki Koike. 2016. “Co-Occurrence of Hyperleukocytosis and Elevated Fibrin-Fibrinogen Degradation Product Levels Is a Risk Factor for Early Intracranial Hemorrhage in Patients with de Novo Acute Leukemia.” International Journal of Hematology 104 (5): 612–20. doi:10.1007/s12185-016-2072-5.